canada clinical guidance

Otitis externa

A Canadian clinical summary of otitis externa, with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.

Source and scope

This 2024 Canadian Family Physician review provides an evidence-based primary-care approach to acute, chronic and necrotizing otitis externa. Product selection still requires current Canadian product information and local antimicrobial guidance.
sources for this section:CFPC otitis externa

Source-attributed clinical priorities

  • Examine the canal and tympanic membrane where possible and distinguish diffuse otitis externa from middle-ear disease or a foreign body.
  • Use canal cleaning when safe and topical therapy selected for tympanic-membrane status; systemic antibiotics are rarely needed for uncomplicated disease.
  • Escalate severe nocturnal pain, granulation, cranial neuropathy, diabetes or immunocompromise because invasive infection is possible.
  • Tragal tenderness and an inflamed canal support otitis externa, while middle-ear disease requires a separate assessment.
sources for this section:CFPC otitis externa

Practical assessment and management workflow

1
Ask about water exposure, instrumentation, hearing aids, diabetes and immunosuppression.
2
Inspect canal edema, discharge, tympanic membrane when visible and spread beyond the canal.
3
Clean gently when appropriate and use a topical preparation compatible with membrane status.
4
Reassess severe obstruction or nonresponse and use a wick or specialist care when delivery is inadequate.
sources for this section:CFPC otitis externa

Safety, red flags and urgent escalation

  • Severe nocturnal pain, granulation tissue or cranial neuropathy in diabetes suggests necrotizing otitis externa.
  • Postauricular swelling or systemic toxicity requires urgent alternative-diagnosis assessment.
  • Avoid aminoglycoside-containing drops when the tympanic membrane may be perforated unless specifically directed.
sources for this section:CFPC otitis externa

Confirm the local pathway before acting

The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CFPC otitis externa

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CFPC otitis externa

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. College of Family Physicians of CanadaApproach to otitis externaDOI 10.46747/cfp.7010617 路 Canadian Family Physician 2024;70:617-623 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.